{"resourceType":"CodeSystem","id":"tbd-codes","meta":{"profile":["http://hl7.org/fhir/StructureDefinition/shareablecodesystem"]},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\"><h2>tbd-codes</h2><div><p>These codes are currently 'TBD-LOINC' codes. The CG WG is requesting formal LOINC codes.</p>\n</div><p>This code system http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">grouper<a name=\"tbd-codes-grouper\"> </a></td><td>grouper</td><td>A means to bundle several observations such as one would find in a genetics test panel.</td></tr><tr><td style=\"white-space:nowrap\">mode-of-inheritance<a name=\"tbd-codes-mode-of-inheritance\"> </a></td><td>mode-of-inheritance</td><td>This is actually LOINC code 79742-3. And the IG will be updated</td></tr><tr><td style=\"white-space:nowrap\">effect-transporter-function<a name=\"tbd-codes-effect-transporter-function\"> </a></td><td>effect-transporter-function</td><td>Predicted phenotype for drug efficacy through transport mechanism. A single marker interpretation value known to increase or decrease the drug's performance.</td></tr><tr><td style=\"white-space:nowrap\">somatic-diagnostic<a name=\"tbd-codes-somatic-diagnostic\"> </a></td><td>somatic-diagnostic</td><td>Finding of whether a particular somatic genotype/haplotype/variation or combination-thereof supports or opposes the diagnosis of a particular cancer. Example values are: Pathognomonic, Supportive, Argues Against, Rules Out.</td></tr><tr><td style=\"white-space:nowrap\">somatic-prognostic<a name=\"tbd-codes-somatic-prognostic\"> </a></td><td>Somatic Prognostic Implication</td><td>Finding of whether a particular somatic genotype/haplotype/variation or combination-thereof predicts a particular outcome for the specified cancer - either on its own or in conjunction with one or more interventions.</td></tr><tr><td style=\"white-space:nowrap\">somatic-prognostic-medication<a name=\"tbd-codes-somatic-prognostic-medication\"> </a></td><td>somatic-prognostic-medication</td><td>The medication or medication class whose implication on the cancer is being predicted. (Same as somatic-predictive-medication).</td></tr><tr><td style=\"white-space:nowrap\">somatic-prognostic-treatment<a name=\"tbd-codes-somatic-prognostic-treatment\"> </a></td><td>somatic-prognostic-treatment</td><td>The non-medication therapy (procedure) whose implication on the cancer outcome is being predicted. E.g. altered diet, radiation therapy, surgery, etc.</td></tr><tr><td style=\"white-space:nowrap\">somatic-predictive<a name=\"tbd-codes-somatic-predictive\"> </a></td><td>Somatic variant predicted effect on Cancer medication</td><td>Finding of whether a particular somatic genotype/haplotype/variation or combination-thereof predicts an impact on medication efficay or prediction of an adverse event caused by a medication. Example values are: Resistant, Responsive, Not-Responsive, Sensitive, Reduced-Sensitivity, Adverse Response.</td></tr><tr><td style=\"white-space:nowrap\">somatic-predictive-medication<a name=\"tbd-codes-somatic-predictive-medication\"> </a></td><td>somatic-predictive-medication</td><td>The medication or medication class whose implication on the cancer is being predicted.</td></tr><tr><td style=\"white-space:nowrap\">associated-cancer<a name=\"tbd-codes-associated-cancer\"> </a></td><td>associated-cancer</td><td>Associated Cancer</td></tr><tr><td style=\"white-space:nowrap\">region-coverage<a name=\"tbd-codes-region-coverage\"> </a></td><td>region-coverage</td><td>Given as a number between 0 and 100. Mean mapped read depth. Obtained by counting total number of mapped reads and divided by the number of bases in the region sequence.</td></tr><tr><td style=\"white-space:nowrap\">functional-annotation<a name=\"tbd-codes-functional-annotation\"> </a></td><td>functional-annotation</td><td>Annotated changes to sequence features caused by this variant. Terms are from the sequence ontology under SO:0001537.</td></tr><tr><td style=\"white-space:nowrap\">exact-start-end<a name=\"tbd-codes-exact-start-end\"> </a></td><td>Variant exact start and end</td><td>The genomic coordinates of the exact genomic range in which the variant resides.</td></tr><tr><td style=\"white-space:nowrap\">inner-start-end<a name=\"tbd-codes-inner-start-end\"> </a></td><td>Variant inner start and end</td><td>The genomic coordinates of the inner genomic range in which the variant might reside.</td></tr><tr><td style=\"white-space:nowrap\">outer-start-end<a name=\"tbd-codes-outer-start-end\"> </a></td><td>Variant outer start and end</td><td>The genomic coordinates of the outer genomic range in which the variant might reside.</td></tr><tr><td style=\"white-space:nowrap\">variant-inheritance<a name=\"tbd-codes-variant-inheritance\"> </a></td><td>Variant inheritance</td><td>A quality inhering in a variant by virtue of its origin. The terms are in the sequence ontology under SO:0001762</td></tr></table></div>"},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/structuredefinition-wg","valueCode":"cg"}],"url":"http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes","version":"1.0.0","name":"ToBeDeterminedCodes","title":"tbd-codes","status":"draft","experimental":false,"date":"2019-08-21T00:00:00+00:00","publisher":"HL7 (Clinical Genomics)","contact":[{"telecom":[{"system":"url","value":"http://hl7.org/fhir"},{"system":"email","value":"fhir@lists.hl7.org"}]}],"description":"These codes are currently 'TBD-LOINC' codes. The CG WG is requesting formal LOINC codes.","caseSensitive":true,"valueSet":"http://hl7.org/fhir/uv/genomics-reporting/ValueSet/tbd-codes","content":"complete","concept":[{"code":"grouper","display":"grouper","definition":"A means to bundle several observations such as one would find in a genetics test panel."},{"code":"mode-of-inheritance","display":"mode-of-inheritance","definition":"This is actually LOINC code 79742-3. And the IG will be updated"},{"code":"effect-transporter-function","display":"effect-transporter-function","definition":"Predicted phenotype for drug efficacy through transport mechanism. A single marker interpretation value known to increase or decrease the drug's performance."},{"code":"somatic-diagnostic","display":"somatic-diagnostic","definition":"Finding of whether a particular somatic genotype/haplotype/variation or combination-thereof supports or opposes the diagnosis of a particular cancer. Example values are: Pathognomonic, Supportive, Argues Against, Rules Out."},{"code":"somatic-prognostic","display":"Somatic Prognostic Implication","definition":"Finding of whether a particular somatic genotype/haplotype/variation or combination-thereof predicts a particular outcome for the specified cancer - either on its own or in conjunction with one or more interventions."},{"code":"somatic-prognostic-medication","display":"somatic-prognostic-medication","definition":"The medication or medication class whose implication on the cancer is being predicted. (Same as somatic-predictive-medication)."},{"code":"somatic-prognostic-treatment","display":"somatic-prognostic-treatment","definition":"The non-medication therapy (procedure) whose implication on the cancer outcome is being predicted. E.g. altered diet, radiation therapy, surgery, etc."},{"code":"somatic-predictive","display":"Somatic variant predicted effect on Cancer medication","definition":"Finding of whether a particular somatic genotype/haplotype/variation or combination-thereof predicts an impact on medication efficay or prediction of an adverse event caused by a medication. Example values are: Resistant, Responsive, Not-Responsive, Sensitive, Reduced-Sensitivity, Adverse Response."},{"code":"somatic-predictive-medication","display":"somatic-predictive-medication","definition":"The medication or medication class whose implication on the cancer is being predicted."},{"code":"associated-cancer","display":"associated-cancer","definition":"Associated Cancer"},{"code":"region-coverage","display":"region-coverage","definition":"Given as a number between 0 and 100. Mean mapped read depth. Obtained by counting total number of mapped reads and divided by the number of bases in the region sequence."},{"code":"functional-annotation","display":"functional-annotation","definition":"Annotated changes to sequence features caused by this variant. Terms are from the sequence ontology under SO:0001537."},{"code":"exact-start-end","display":"Variant exact start and end","definition":"The genomic coordinates of the exact genomic range in which the variant resides."},{"code":"inner-start-end","display":"Variant inner start and end","definition":"The genomic coordinates of the inner genomic range in which the variant might reside."},{"code":"outer-start-end","display":"Variant outer start and end","definition":"The genomic coordinates of the outer genomic range in which the variant might reside."},{"code":"variant-inheritance","display":"Variant inheritance","definition":"A quality inhering in a variant by virtue of its origin. The terms are in the sequence ontology under SO:0001762"}]}